Sign in

Duncan Angove

Director at HON
Board

About Duncan B. Angove

Independent director at Honeywell (HON) since 2018 (Years of Service: 7) and age 58. Current CEO of Blue Yonder Group, Inc.; prior senior roles at Arcspring, Infor, Oracle Retail, and Retek, bringing deep enterprise software and digital transformation expertise. Determined independent under Nasdaq/SEC rules and serves on two key board committees (CGRC and MDCC) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Blue Yonder Group, Inc.Chief Executive OfficerJul 2022–PresentLeads digital supply chain/omnichannel cloud software; global operating experience
Arcspring LLCManaging Partner2019–Jul 2022Next‑gen PE combining capital/technology/ops/design thinking
Infor, Inc.President2010–2018Enterprise software; strategy, M&A, sales, product development
Oracle Corporation (Retail GBU)SVP & GM2005–2010Retail enterprise software; cybersecurity/data privacy compliance
Retek Inc.Various roles1997–2005Public retail software provider; roles of increasing responsibility

External Roles

CategoryDetails
Current public company boardsNone
Past public company boardsNone
Executive roleCEO, Blue Yonder Group, Inc.

Board Governance

  • Committee assignments: Corporate Governance & Responsibility (CGRC) – Member; Management Development & Compensation (MDCC) – Member .
  • Independence: Board affirmatively determined Mr. Angove is independent (audit/compensation enhanced criteria apply to relevant committees) .
  • Attendance: 2024 Board held 9 meetings (100% attendance of regularly scheduled meetings); committee average attendance 99%; each director ≥98% aggregate attendance .
  • Years of service: 7; Independent status shown in proxy slate .

Fixed Compensation

ComponentProgram Terms (Directors)2024 Amount (Angove)
Board cash retainer$120,000 per annum; paid quarterly $199,148 fees earned (includes committee fees/deferrals)
Committee membership fees$10,000 per committee ($15,000 for Audit) per annum Included in fees earned
Committee chair feesAudit Chair $40,000; MDCC Chair $25,000; CGRC Chair $20,000 per annum Not applicable (member)
Common stock equivalents (deferred)$60,000 credited annually; paid in cash post‑service Included in program; individual table shows stock awards separately
Other benefitsMatching charitable contributions up to $25,000; business travel accident insurance; limited aircraft use $42 all other compensation

Total 2024 Director Compensation (Angove): $329,234 (Fees $199,148; Stock awards $130,044; Other $42; no options) .

Performance Compensation

Equity ElementGrant Terms2024 Angove Grant
Annual RSU grant$130,000 target value; vests on earliest of April 15 preceding first anniversary, death/disability, Change in Control, or ≥10 years board service in good standing Stock awards: $130,044 aggregate grant date fair value
Options (director program)Not granted to non‑employee directors in 2024 $0 option awards

No formulaic performance metrics apply to director equity grants; awards are time‑based to align directors with shareholder outcomes .

Other Directorships & Interlocks

TopicDisclosure
Commercial relationshipsHoneywell had arm’s‑length ordinary‑course commercial relationships with certain companies where directors serve or served (includes Blue Yonder Group, Inc. for Mr. Angove); combined purchases/sales <1% of consolidated gross sales for Honeywell and the other companies in each of last three years .
Related party oversightCGRC reviews related party transactions for potential conflicts and ensures appropriate controls; formal policy and Code of Business Conduct reporting apply .

Expertise & Qualifications

  • Senior technology industry leader with global operating experience in software/digital transformation; expertise in enterprise cloud, infrastructure software, IoT, and cybersecurity/data privacy. Extensive M&A, strategy, sales, marketing, and product development background .

Equity Ownership

MeasureAmount
Beneficial ownership (Common)2,269 shares
Right to acquire within 60 days10,527 shares (options/RSUs)
Other stock‑based holdings (deferred)6,396 share equivalents
Total beneficial ownership (SEC definition)19,192 shares/equivalents (<1% of outstanding)
Outstanding awards (Dec 31, 2024)Options: 10,899; RSUs: 647; Deferred comp plan units (non‑elective): 2,509
Director ownership guidelineMinimum holdings ≥5x cash retainer ($600,000) within five years; all current directors except Lee, Watson, Lamach, Williamson have met threshold (Angove has met)
Hedging/pledging policyHedging, pledging, short sales, and trading in options on Honeywell securities are prohibited for directors

Governance Assessment

  • Committee engagement: Dual membership on CGRC and MDCC positions Angove at the center of director nominations/ESG oversight (CGRC) and executive compensation/succession (MDCC), supporting board effectiveness .
  • Independence & attendance: Affirmed independent; strong attendance metrics at board/committee level suggest high engagement and governance quality .
  • Alignment: Director pay mix balances cash and time‑vested equity; no options to directors in 2024; Angove meets stringent stock ownership guideline, reinforcing alignment with shareholders .
  • Potential conflicts: Blue Yonder relationships disclosed as arm’s‑length and immaterial (<1% of sales), with CGRC oversight mitigating conflict risk (monitor for changes in transaction scope) .
  • RED FLAGS: None evident from proxy; no pledging/hedging permitted; no related‑party transactions triggering independence concerns; continue monitoring for any evolving commercial ties with Blue Yonder or compensation/consulting arrangements not covered in the proxy .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%